Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_assertion type Assertion NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_head.
- NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_assertion description "[These results suggest that PPAR? agonist DIM-C can be an excellent alternative to bladder tumors resistant to EGFR inhibition and combination efficacy might be achieved in a schedule-specific manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_provenance.
- NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_assertion evidence source_evidence_literature NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_provenance.
- NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_assertion SIO_000772 23409107 NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_provenance.
- NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_assertion wasDerivedFrom befree-2016 NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_provenance.
- NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_assertion wasGeneratedBy ECO_0000203 NP1053069.RAqO70uxniu6x4HteqvO6JbgARsRUqcypUgLXx3HSN2M8130_provenance.